[Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice]
- PMID: 17520810
[Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice]
Abstract
To observe the pharmacokinetic and tissue-distribution characters of 5-flourouracil magnetic albumin deuto-microsphere (5-Fu-MAD) in normal and tumor-bearing mice, HPLC method for the determination of 5-Fu in plasma and tissues was established and applied to determine 5-Fu in mouse plasma and tissue samples. A Flame atomic absorption spectrometer was used to detect the iron concentration in mouse tissue. Plasma concentration-time curves of free 5-Fu, 5-Fu-MAD and 5-Fu-MAD plus the magnetic frame (MF) conformed to two compartment model of first order absorption and they had C(max) of 34.9, 7.95 and 5.97 mg x L(-1); T1/2 (Ke) of 22.26, 76.0 and 124.6 min, V(d) of 3.28, 30.7 and 66.1 L x kg; AUC(0-t), of 233.9, 78.3 and 50.2 mg x min x L(-1); AUC(0-infinity) of 237.2, 89.3 and 68.1 mg x min x L(-1), respectively. The distribution of 5-Fu and iron was the highest in the plenty blood perfusion organs like the liver, tumor, spleen and lung, while lower in the kidney and heart and lowest in brain and muscle. The tissue distribution of muscle and tumor increased significantly when a magnetic frame was inserted there. The pharmacokinetics and tissue distribution of 5-Fu-MAD exhibited sustained-release and target characteristics.
Similar articles
-
Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.Acta Pharmacol Sin. 2005 Feb;26(2):250-6. doi: 10.1111/j.1745-7254.2005.00530.x. Acta Pharmacol Sin. 2005. PMID: 15663907
-
Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.Pharmazie. 2004 Sep;59(9):709-12. Pharmazie. 2004. PMID: 15497754
-
Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.Anticancer Res. 2004 May-Jun;24(3a):1699-704. Anticancer Res. 2004. PMID: 15274343
-
Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.Eur J Pharm Sci. 2009 Jan 31;36(1):20-38. doi: 10.1016/j.ejps.2008.10.024. Epub 2008 Nov 11. Eur J Pharm Sci. 2009. PMID: 19041394 Review.
-
Albumin microspheres as drug carriers.Crit Rev Ther Drug Carrier Syst. 1985;2(1):19-63. Crit Rev Ther Drug Carrier Syst. 1985. PMID: 3913529 Review.
Cited by
-
Specifics of Pharmacokinetics and Biodistribution of 5-Fluorouracil Polymeric Complex.Molecules. 2023 Dec 15;28(24):8096. doi: 10.3390/molecules28248096. Molecules. 2023. PMID: 38138585 Free PMC article.